by Jessica Casebolt | Mar 2, 2023 | D.C. News, Tea Leaves
House Oversight and Accountability Committee Chairman James Comer announced Wednesday that he is launching an investigation into pharmacy benefit managers (PBM) and actions that increase health care costs for patients. Comer called for enhanced transparency in the PBM...
by Jessica Casebolt | Mar 1, 2023 | D.C. News, Tea Leaves
Federal health advisers narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respiratory illness known as RSV. The Food and Drug Administration panel voted 7-4 on two separate questions of...
by Jessica Casebolt | Feb 27, 2023 | D.C. News, Tea Leaves
The federal government is moving to require doctors to evaluate patients in person before writing prescriptions for some controlled medications, such as Adderall and OxyContin. The Drug Enforcement Administration announced Friday that it is seeking to revert rule...
by Jessica Casebolt | Feb 21, 2023 | D.C. News, Tea Leaves
Two House committees, and potentially several more, are getting involved in investigating the origins of COVID, setting them up for a lot of overlap and even friction. What comes out of these COVID-origin investigations could have implications for federal funding of...
by Jordana Choucair | Feb 9, 2023 | D.C. News
The Biden administration will soon release a roadmap to transition the U.S. out of the COVID-19 public health emergency. According to sources, the roadmap intends to try to lay out for the public in a clear way what the end of the declaration “does and does not...
by Jordana Choucair | Feb 8, 2023 | D.C. News
The Biden administration told the Supreme Court Tuesday that Title 42 will end in May when the COVID-19 public health emergency expires. Title 42 is a Trump-era public health authority that allows border officials to turn away migrants encountered at the US-Mexico...
Recent Comments